Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ELV
REGN
Add up to 3 more stocks
ELV
Elevance Health Inc.
+0.52%
$418.72+2.18Delayed quote: Sep 11, 2026, 4:00 PM EDT
Market Cap
$90.81B
52W Range
$274.84 - $436.24
REGN
Regeneron Pharmaceuticals, Inc.
-1.48%
$781.49-11.77Delayed quote: Sep 11, 2026, 4:00 PM EDT
Market Cap
$80.51B
52W Range
$541.00 - $859.34
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 18.61 | 19.33 |
| Forward P/E | 15.42 | 14.40 |
| P/B Ratio | 2.02 | 2.54 |
| P/S Ratio | 0.45 | 5.18 |
| P/FCF Ratio | 14.44 | 22.86 |
| EV/EBITDA | 13.82 | 17.79 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 25.6% | 84.9% |
| Operating Margin | 3.5% | 25.6% |
| Net Margin | 2.5% | 27.9% |
| ROE | 11.1% | 13.7% |
| ROA | 3.9% | 10.4% |
| ROIC | 6.3% | 9.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.05 | 3.34 |
| Quick Ratio | 2.05 | 2.78 |
| Debt/Equity | 0.69 | 0.06 |
| Interest Coverage | 5.79 | 81.69 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 1.6% | 0.5% |
| Payout Ratio | 30.5% | 9.2% |
| Yrs of Dividend Growth | 14 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.